An observational study in Diabetes, STEMI and NSTEMI, sponsored by Stiftung Institut fuer Herzinfarktforschung. Completed at 2 sites in Germany. Per ClinicalTrials.gov, last updated 2024-12-20.
Sponsored by Stiftung Institut fuer Herzinfarktforschung · Observational
The Sweetheart register (Risk management of Diabetics with acute myocardial infarction) documents both the prevalence of pathologic glucose metabolism in consecutive high-risk patients with STEMI and NSTEMI in daily hospital routine as well as the anti-diabetic acute and long-term therapy. Furthermore the register will provide data about the implementation of new guidelines for the interventional and adjuvant medical therapy of STEMI and NSTEMI.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's enrollment of 2,772 is above the median of 500 across 983 observational studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Stiftung Institut fuer Herzinfarktforschung is the lead sponsor of 25 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
all consecutive patients with acute (no older than 24 h) ST-Elevation Myocardial infarction or acute (no older than 24 h) Non-ST-Elevation Myocardial infarction.
Exclusion Criteria:
Documentation of the characteristics consecutive patients with acute STEMI or NSTEMI in daily hospital routine in Germany
Time frame: 04/01/2007-09/30/2009
Documentation of the fraction of patients with (I) a previous know Diabetes Mellitus (DM) type I and II, (II) a newly diagnosed DM, (III) diagnosed with IFG or IGT for the first time
Time frame: 04/01/2007-09/30/2009
Documentation of acute invasive and adjuvant medicamentous therapy of STEMI and NSREMI in hospital daily routine in Germany
Time frame: 04/01/2007-09/30/2009
Documentation of diabetic therapy during the acute phase of a myocardial infarction
Time frame: 04/01/2007-09/30/2009
Documentation of the hospital mortality, the serious but non-fatal complications (stroke, re-myocardial infarction) and other bleeding complications
Time frame: 04/01/2007-09/30/2009
Verification of the implementation of a therapy according to the guidelines for STEMI / NSTEMI in daily hospital routine
Time frame: 04/01/2007-09/30/2009
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stiftung Institut fuer Herzinfarktforschung